Investor profile
HCVC has backed 13 European tech companies across 17 funding rounds between 2020 and 2026, joining rounds totalling €200M. Most active in Healthtech and Energy. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Cowboy | Belgium | 2 | €95M |
| Transmutex | Switzerland | 1 | €21M |
| Chiral Nano | Switzerland | 2 | €14M |
| Remedee Labs | France | 1 | €12M |
| Delian Alliance Industries | Greece |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Cowboy | Series C | €72M | 2022-01 |
| Cowboy | Series B | €23M | 2020-07 |
| Transmutex | Series A | €21M | 2024-01 |
| Remedee Labs |
| 1 |
| €12M |
| Surge | France | 2 | €10M |
| Sarcura | Austria | 1 | €7.0M |
| Atmio | Germany | 2 | €6.4M |
| Lendurai | Estonia | 1 | €5.6M |
| kyron.bio | France | 1 | €5.5M |
| Fuse Vectors | Denmark | 1 | €5.0M |
| Orakl Oncology | France | 1 | €3.0M |
| Numi | Germany | 1 | €3.0M |
| €12M |
| 2022-12 |
| Delian Alliance Industries | Series A | €12M | 2025-07 |
| Chiral Nano | Seed | €10M | 2026-02 |
| Surge | Other | €7.5M | 2024-03 |
| Sarcura | Seed | €7.0M | 2022-11 |
| Lendurai | Seed | €5.6M | 2025-06 |
| kyron.bio | Other | €5.5M | 2025-05 |
